newsfilter

$RBCN News

Last published 1y ago

  • 1y agoRBCNApproval of Chlorpromazine Hydrochloride, Anda #216678FDA Approved DrugsApproval Date: 10/10/2025; Drug Name: Chlorpromazine Hydrochloride, Anda #216678; Active Ingredients: CHLORPROMAZINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 216678
  • 1y agoJANLRBCNRubicon Technology, Inc. to acquire Janel Group LLCGlobeNewswireBENSENVILLE, Ill. and NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rubicon Technology, Inc. (OTCQB:RBCN) ("Rubicon") and Janel Corporation (OTCQX:JANL) ("Janel Corp") today announced that they have entered into a
  • 1y agoRBCNApproval of Fluticasone Propionate, Anda #219060FDA Approved DrugsApproval Date: 08/15/2025; Drug Name: Fluticasone Propionate, Anda #219060; Active Ingredients: FLUTICASONE PROPIONATE; Company: Rubicon; Submission Status: Approval; Application Number: 219060
  • 1y agoRBCNApproval of Tramadol Hydrochloride, Anda #208708 (Labeling)FDA Approved DrugsApproval Date: 07/01/2025; Drug Name: Tramadol Hydrochloride, Anda #208708; Active Ingredients: TRAMADOL HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 208708
  • 1y agoRBCNApproval of Amitriptyline Hydrochloride, Anda #215376 (Labeling)FDA Approved DrugsApproval Date: 06/24/2025; Drug Name: Amitriptyline Hydrochloride, Anda #215376; Active Ingredients: AMITRIPTYLINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 215376
  • 1y agoRBCNApproval of Labetalol Hydrochloride, Anda #211953 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 06/06/2025; Drug Name: Labetalol Hydrochloride, Anda #211953; Active Ingredients: LABETALOL HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 211953
  • 1y agoRBCNApproval of Valsartan, Anda #216460FDA Approved DrugsApproval Date: 06/05/2025; Drug Name: Valsartan, Anda #216460; Active Ingredients: VALSARTAN; Company: Rubicon; Submission Status: Approval; Application Number: 216460
  • 1y agoRBCNApproval of Baclofen, Anda #214445 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 06/03/2025; Drug Name: Baclofen, Anda #214445; Active Ingredients: BACLOFEN; Company: Rubicon; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 214445
  • 1y agoRBCNApproval of Topiramate, Anda #216683FDA Approved DrugsApproval Date: 05/27/2025; Drug Name: Topiramate, Anda #216683; Active Ingredients: TOPIRAMATE; Company: Rubicon; Submission Status: Approval; Application Number: 216683
  • 1y agoRBCNApproval of Metoprolol Tartrate, Anda #200981 (Labeling)FDA Approved DrugsApproval Date: 05/22/2025; Drug Name: Metoprolol Tartrate, Anda #200981; Active Ingredients: METOPROLOL TARTRATE; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 200981
  • 1y agoRBCNApproval of Labetalol Hydrochloride, Anda #211953 (Labeling)FDA Approved DrugsApproval Date: 05/07/2025; Drug Name: Labetalol Hydrochloride, Anda #211953; Active Ingredients: LABETALOL HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 211953
  • 1y agoRBCNApproval of Guanfacine Hydrochloride, Anda #219689FDA Approved DrugsApproval Date: 04/15/2025; Drug Name: Guanfacine Hydrochloride, Anda #219689; Active Ingredients: GUANFACINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 219689
  • 1y agoRBCNApproval of Bisoprolol Fumarate, Anda #075643 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 03/07/2025; Drug Name: Bisoprolol Fumarate, Anda #075643; Active Ingredients: BISOPROLOL FUMARATE; Company: Rubicon; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 075643
  • 1y agoRBCNApproval of Ipratropium Bromide, Anda #219222FDA Approved DrugsApproval Date: 01/14/2025; Drug Name: Ipratropium Bromide, Anda #219222; Active Ingredients: IPRATROPIUM BROMIDE; Company: Rubicon; Submission Status: Approval; Application Number: 219222
  • 1y agoRBCNApproval of Bumetanide, Anda #213942FDA Approved DrugsApproval Date: 12/27/2024; Drug Name: Bumetanide, Anda #213942; Active Ingredients: BUMETANIDE; Company: Rubicon; Submission Status: Approval; Application Number: 213942
  • 1y agoRBCNApproval of Pregabalin, Anda #215249 (Labeling)FDA Approved DrugsApproval Date: 12/12/2024; Drug Name: Pregabalin, Anda #215249; Active Ingredients: PREGABALIN; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 215249
  • 1y agoRBCNApproval of Diclofenac Sodium, Anda #216548 (Labeling)FDA Approved DrugsApproval Date: 11/21/2024; Drug Name: Diclofenac Sodium, Anda #216548; Active Ingredients: DICLOFENAC SODIUM; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 216548
  • 1y agoRBCNApproval of Diclofenac Potassium, Anda #075229 (Labeling)FDA Approved DrugsApproval Date: 11/21/2024; Drug Name: Diclofenac Potassium, Anda #075229; Active Ingredients: DICLOFENAC POTASSIUM; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 075229
  • 1y agoRBCNApproval of Ipratropium Bromide, Anda #219221FDA Approved DrugsApproval Date: 11/15/2024; Drug Name: Ipratropium Bromide, Anda #219221; Active Ingredients: IPRATROPIUM BROMIDE; Company: Rubicon; Submission Status: Approval; Application Number: 219221
  • 2y agoRBCNApproval of Clomiphene Citrate, Anda #216545FDA Approved DrugsApproval Date: 11/12/2024; Drug Name: Clomiphene Citrate, Anda #216545; Active Ingredients: CLOMIPHENE CITRATE; Company: Rubicon; Submission Status: Approval; Application Number: 216545
  • 2y agoRBCNApproval of Potassium Chloride, Anda #215725 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 08/22/2024; Drug Name: Potassium Chloride, Anda #215725; Active Ingredients: POTASSIUM CHLORIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 215725
  • 2y agoRBCNApproval of Glipizide, Anda #214874 (Labeling)FDA Approved DrugsApproval Date: 07/15/2024; Drug Name: Glipizide, Anda #214874; Active Ingredients: GLIPIZIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 214874
  • 2y agoRBCNApproval of Tranexamic Acid, Anda #218320FDA Approved DrugsApproval Date: 06/11/2024; Drug Name: Tranexamic Acid, Anda #218320; Active Ingredients: TRANEXAMIC ACID; Company: Rubicon; Submission Status: Approval; Application Number: 218320
  • 2y agoRBCNApproval of Carbidopa And Levodopa, Anda #217482FDA Approved DrugsApproval Date: 06/04/2024; Drug Name: Carbidopa And Levodopa, Anda #217482; Active Ingredients: CARBIDOPA; LEVODOPA; Company: Rubicon; Submission Status: Approval; Application Number: 217482
  • 2y agoRBCNApproval of Oxcarbazepine, Anda #207717FDA Approved DrugsApproval Date: 03/05/2024; Drug Name: Oxcarbazepine, Anda #207717; Active Ingredients: OXCARBAZEPINE; Company: Rubicon; Submission Status: Approval; Application Number: 207717
  • 2y agoRBCNApproval of Nitroglycerin, Anda #209779 (Labeling)FDA Approved DrugsApproval Date: 02/20/2024; Drug Name: Nitroglycerin, Anda #209779; Active Ingredients: NITROGLYCERIN; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 209779
  • 2y agoRBCNApproval of Baclofen, Anda #209102 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 02/05/2024; Drug Name: Baclofen, Anda #209102; Active Ingredients: BACLOFEN; Company: Rubicon; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 209102
  • 3y agoRBCNApproval of Baclofen, Anda #209102 (Labeling)FDA Approved DrugsApproval Date: 09/12/2023; Drug Name: Baclofen, Anda #209102; Active Ingredients: BACLOFEN; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 209102
  • 3y agoRBCNApproval of Nortriptyline Hydrochloride, Anda #217731FDA Approved DrugsApproval Date: 08/15/2023; Drug Name: Nortriptyline Hydrochloride, Anda #217731; Active Ingredients: NORTRIPTYLINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 217731
  • 3y agoRBCNApproval of Lithium Citrate, Anda #218036FDA Approved DrugsApproval Date: 08/14/2023; Drug Name: Lithium Citrate, Anda #218036; Active Ingredients: LITHIUM CITRATE; Company: Rubicon; Submission Status: Approval; Application Number: 218036
  • 3y agoRBCNApproval of Dihydroergotamine Mesylate, Anda #216881FDA Approved DrugsApproval Date: 06/22/2023; Drug Name: Dihydroergotamine Mesylate, Anda #216881; Active Ingredients: DIHYDROERGOTAMINE MESYLATE; Company: Rubicon; Submission Status: Approval; Application Number: 216881
  • 3y agoRBCNApproval of Potassium Chloride, Anda #216321FDA Approved DrugsApproval Date: 06/16/2023; Drug Name: Potassium Chloride, Anda #216321; Active Ingredients: POTASSIUM CHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 216321
  • 3y agoRBCNApproval of Diclofenac Sodium, Anda #216548FDA Approved DrugsApproval Date: 05/11/2023; Drug Name: Diclofenac Sodium, Anda #216548; Active Ingredients: DICLOFENAC SODIUM; Company: Rubicon; Submission Status: Approval; Application Number: 216548
  • 3y agoRBCNApproval of Amitriptyline Hydrochloride, Anda #215376FDA Approved DrugsApproval Date: 05/01/2023; Drug Name: Amitriptyline Hydrochloride, Anda #215376; Active Ingredients: AMITRIPTYLINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 215376
  • 3y agoRBCNApproval of Cevimeline Hydrochloride, Anda #216682FDA Approved DrugsApproval Date: 04/06/2023; Drug Name: Cevimeline Hydrochloride, Anda #216682; Active Ingredients: CEVIMELINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 216682
  • 3y agoRBCNApproval of Lidocaine Hydrochloride, Anda #216780FDA Approved DrugsApproval Date: 03/28/2023; Drug Name: Lidocaine Hydrochloride, Anda #216780; Active Ingredients: LIDOCAINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 216780
  • 3y agoRBCNTentative Approval of Baclofen, Anda #214445FDA Approved DrugsApproval Date: 03/13/2023; Drug Name: Baclofen, Anda #214445; Active Ingredients: BACLOFEN; Company: Rubicon; Submission Status: Tentative Approval; Application Number: 214445
  • 3y agoRBCNApproval of Baclofen, Anda #217324FDA Approved DrugsApproval Date: 02/22/2023; Drug Name: Baclofen, Anda #217324; Active Ingredients: BACLOFEN; Company: Rubicon; Submission Status: Approval; Application Number: 217324
  • 3y agoRBCNApproval of Oxybutynin Chloride, Anda #214415 (Labeling)FDA Approved DrugsApproval Date: 01/27/2023; Drug Name: Oxybutynin Chloride, Anda #214415; Active Ingredients: OXYBUTYNIN CHLORIDE; Company: Rubicon; Submission Status: Approval; Submission Classification: Labeling; Application Number: 214415
  • 3y agoRBCNApproval of Loperamide Hydrochloride, Anda #216876FDA Approved DrugsApproval Date: 01/26/2023; Drug Name: Loperamide Hydrochloride, Anda #216876; Active Ingredients: LOPERAMIDE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 216876
  • 3y agoRBCNApproval of Gabapentin, Anda #216492FDA Approved DrugsApproval Date: 01/18/2023; Drug Name: Gabapentin, Anda #216492; Active Ingredients: GABAPENTIN; Company: Rubicon; Submission Status: Approval; Application Number: 216492
  • 3y agoRBCNApproval of Dicyclomine Hydrochloride, Anda #216736FDA Approved DrugsApproval Date: 12/14/2022; Drug Name: Dicyclomine Hydrochloride, Anda #216736; Active Ingredients: DICYCLOMINE HYDROCHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 216736
  • 3y agoRBCNRubicon Technology Announces Voluntary Delisting from NasdaqGlobeNewswireBensenville, IL , Dec. 13, 2022 (GLOBE NEWSWIRE) -- Rubicon Technology, Inc. (NASDAQ:RBCN) announced that it has notified The Nasdaq Stock Market LLC ("Nasdaq") of the Company's decision to voluntarily delist its
  • 4y agoRBCNApproval of Carbidopa And Levodopa, Anda #216505FDA Approved DrugsApproval Date: 09/21/2022; Drug Name: Carbidopa And Levodopa, Anda #216505; Active Ingredients: CARBIDOPA; LEVODOPA; Company: Rubicon; Submission Status: Approval; Application Number: 216505
  • 4y agoRBCNApproval of Acyclovir, Anda #215724FDA Approved DrugsApproval Date: 08/18/2022; Drug Name: Acyclovir, Anda #215724; Active Ingredients: ACYCLOVIR; Company: Rubicon; Submission Status: Approval; Application Number: 215724
  • 4y agoRBCNRubicon Technology, Inc. Sets Record Date for its $11.00 per share Cash DistributionGlobeNewswireBENSENVILLE, IL., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rubicon Technology, Inc. (NASDAQ:RBCN) ("Rubicon" or the "Company") announced today that, in connection with the cash tender offer (the "Offer") by Janel Corporation ("Janel") for up to 45% of Rubicon
  • 4y agoRBCNApproval of Oxcarbazepine, Anda #077747 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 08/04/2022; Drug Name: Oxcarbazepine, Anda #077747; Active Ingredients: OXCARBAZEPINE; Company: Rubicon; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 077747
  • 4y agoRBCNApproval of Potassium Chloride, Anda #215725FDA Approved DrugsApproval Date: 07/25/2022; Drug Name: Potassium Chloride, Anda #215725; Active Ingredients: POTASSIUM CHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 215725
  • 4y agoRBCNApproval of Isosorbide Dinitrate, Anda #215723FDA Approved DrugsApproval Date: 07/08/2022; Drug Name: Isosorbide Dinitrate, Anda #215723; Active Ingredients: ISOSORBIDE DINITRATE; Company: Rubicon; Submission Status: Approval; Application Number: 215723
  • 4y agoRBCNApproval of Potassium Chloride, Anda #214108FDA Approved DrugsApproval Date: 03/24/2022; Drug Name: Potassium Chloride, Anda #214108; Active Ingredients: POTASSIUM CHLORIDE; Company: Rubicon; Submission Status: Approval; Application Number: 214108